Article metrics

Download PDFPDF

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: October 2023 to June 2024

AbstractFullPdf
Oct 202324206
Nov 2023698665129
Dec 2023635600135
Jan 202438237293
Feb 202420619369
Mar 2024293284104
Apr 202430429781
May 202421321380
Jun 202412612052
Total28812764749